Main
>
ONCOLOGY (**)
>
Kidney Cancer>RCC>MET ***
>
Treatment
>
USA. M. PembrolizuMAb+Axitinib
>
(*) EU Approval Date: 2019. 09.04
(*) EU Approval Date: 2019. 09.04's products
This section has no products